找回密碼
 To register

QQ登錄

只需一步,快速開(kāi)始

掃一掃,訪問(wèn)微社區(qū)

打印 上一主題 下一主題

Titlebook: Advantages and Problems with Non-Opioids in Pain Management; Vancouver, Canada, A Michael J. Parnham Conference proceedings 1997 Birkh?user

[復(fù)制鏈接]
11#
發(fā)表于 2025-3-23 13:18:27 | 只看該作者
12#
發(fā)表于 2025-3-23 15:08:36 | 只看該作者
Introduction,Effective though they are in the treatment of a wide variety of painful conditions, opioids are not always the most suitable analgesic therapy. Tried and tested non-opioid analgesics are frequently preferable, especially for the treatment of mild to moderate pain, because of their lower incidence of side-effects or more relevant sites of action.
13#
發(fā)表于 2025-3-23 20:14:59 | 只看該作者
14#
發(fā)表于 2025-3-24 00:59:47 | 只看該作者
Non-opioids in cancer pain management,With all the elegant delivery forms now available for opioids in the treatment of cancer pain, it may seem to some that non-opioids have little place in the management of pain for this indication. This impression requires correction.
15#
發(fā)表于 2025-3-24 02:35:02 | 只看該作者
16#
發(fā)表于 2025-3-24 06:51:25 | 只看該作者
17#
發(fā)表于 2025-3-24 11:38:55 | 只看該作者
http://image.papertrans.cn/a/image/150389.jpg
18#
發(fā)表于 2025-3-24 15:02:48 | 只看該作者
Overview: 978-3-7643-5678-1978-3-0348-8865-3
19#
發(fā)表于 2025-3-24 22:34:47 | 只看該作者
https://doi.org/10.1007/978-981-99-1098-4c efficacy of dipyrone is broad and comparable to that of the non-steroidal anti-inflammatory drugs (NSAIDs) and tramadol. Because dipyrone is a weak cyclo-oxygenase inhibitor, its use is not associated with gastric irritation, an important advantage for long-term administration. Uniquely, dipyrone
20#
發(fā)表于 2025-3-25 01:20:30 | 只看該作者
https://doi.org/10.1007/978-981-99-1098-4rofile and incidence of other AEs are not taken into account. An approach to the evaluation of the public health impact of AEs with non-opioid analgesics has now been taken in which the total risk of short-term use of these drugs in the community was estimated. The three dimensional approach involve
 關(guān)于派博傳思  派博傳思旗下網(wǎng)站  友情鏈接
派博傳思介紹 公司地理位置 論文服務(wù)流程 影響因子官網(wǎng) 吾愛(ài)論文網(wǎng) 大講堂 北京大學(xué) Oxford Uni. Harvard Uni.
發(fā)展歷史沿革 期刊點(diǎn)評(píng) 投稿經(jīng)驗(yàn)總結(jié) SCIENCEGARD IMPACTFACTOR 派博系數(shù) 清華大學(xué) Yale Uni. Stanford Uni.
QQ|Archiver|手機(jī)版|小黑屋| 派博傳思國(guó)際 ( 京公網(wǎng)安備110108008328) GMT+8, 2025-10-13 00:48
Copyright © 2001-2015 派博傳思   京公網(wǎng)安備110108008328 版權(quán)所有 All rights reserved
快速回復(fù) 返回頂部 返回列表
互助| 福海县| 罗甸县| 嵩明县| 禄劝| 民县| 泸州市| 黄石市| 海城市| 隆昌县| 南靖县| 五台县| 潼南县| 龙口市| 东乡县| 淮南市| 罗源县| 且末县| 共和县| 葫芦岛市| 清苑县| 汉阴县| 宜黄县| 阿勒泰市| 湘潭县| 麦盖提县| 武功县| 鄂尔多斯市| 华宁县| 集安市| 樟树市| 阳江市| 金秀| 乌鲁木齐县| 东平县| 大渡口区| 南和县| 灵川县| 高台县| 敦化市| 会泽县|